Array $65.7m offering will advance oncology programs
This article was originally published in Scrip
Executive Summary
Array BioPharma has priced a public offering of 18 million shares of common stock at a price of $3.65 per share in a bid to raise $65.7 million. The offering is expected to close on 15 November, with a 30-day option to purchase an additional 2.7 million shares to cover over-allotments.